
Is it a good time to buy shares in PureTech Health?
Although the markets rout of the past week has been indiscriminate, for biotechnology, a riskier asset class at the best of times, it has felt brutal. The London-listed biotech companies to have been sold off have included PureTech Health, which has lost …